Clinical Trial Update: Safety and Efficacy of Andecaliximab (GS-5745) in Adults With Moderately to Severely Active Ulcerative Colitis [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update for Andecaliximab (GS-5745) in adults with moderately to severely active ulcerative colitis; trial phases 2 and 3 were terminated with res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Andecaliximab

Snippet

Sponsor: Gilead Sciences | Conditions: Ulcerative Colitis | Phase 2, Phase 3 | Status: TERMINATED | Results posted: 2019-04-10